Biostar Pharmaceuticals Inc  

(Public, NASDAQ:BSPM)   Watch this stock  
Find more results for BSPM
1.56
+0.06 (4.00%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.41 - 1.58
52 week 0.91 - 2.27
Open 1.52
Vol / Avg. 606,068.00/211,605.00
Mkt cap 24.30M
P/E 4.63
Div/yield     -
EPS 0.34
Shares 15.48M
Beta 2.53
Inst. own 4%
Apr 15, 2015
Full Year 2014 Biostar Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 18.47% 7.89%
Operating margin -8.26% -2.14%
EBITD margin - 4.50%
Return on average assets 13.30% 6.52%
Return on average equity 15.03% 7.18%
Employees 438 -
CDP Score - -

Address

No. 588 Shiji Xi Avenue
XIANYANG, 712046
China
+86-29-33686638 (Phone)
+86-29-33685386 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Biostar Pharmaceuticals, Inc. (Biostar) is a China-based holding company. The Company, through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entity (VIE) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People�s Republic of China. The Company's product is the Xin Ao Xing Oleanolic Acid Capsule, an over-the- counter (OTC) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. Its product line also includes five other OTC products, 10 prescription-based pharmaceuticals, six nutriceuticals or health products and one medical device. The Company completed the acquisition of Shaanxi Weinan Huaren Pharmaceuticals, Ltd (Shaanxi Weinan). The Company's products are sold in over 27 provinces in the People�s Republic of China through 68 distributors.

Officers and directors

Ronghua Wang Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Qinghua Liu Interim Chief Financial Officer, Director
Age: 46
Bio & Compensation  - Reuters
Zhenghong Wang Chief Operating Officer
Age: 33
Bio & Compensation  - Reuters
Shuang Gong Secretary of Board
Age: 46
Bio & Compensation  - Reuters
King Fai Leung Independent Director
Age: 42
Bio & Compensation  - Reuters
Zhongyang Shang Independent Director
Age: 62
Bio & Compensation  - Reuters
Haipeng Wu Independent Director
Age: 56
Bio & Compensation  - Reuters